Search
Powered By HealthLine
Special Offers
TV Specials
 Learn about an Effective Alzheimer's Medication
 Bipolar Education Health Center
 Osteoarthritis of the Knee Solution Center
 Heartburn Education Center
 Breast Cancer Health Center
 Crohn's Disease Health Center
 Schizophrenia Education Center
Top Features
 Depression
 Schizophrenia
 Breast Cancer
 Bipolar
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Low-Dose Aspirin Won't Help Aging Brain

Major 10-year study of older women shows no differences

By Amanda Gardner
HealthDay Reporter


Related Encyclopedia
 border=
Acoustic Neurinoma
Alzheimer's Disease
Amenorrhea
Amniocentesis
More...

Related Healthscout Videos
 border=
Brain Surgery with Water?
Preventing Breast Cancer
Tracking Breast Cancer Treatment
Howard: The Helping Hand for Stroke Survivors
More...

Related Animations
 border=
Alzheimer's Disease Video Animation
Angioplasty
Breast Reduction
Breast Self-Exam Video
More...

Related Drug Information
 border=
Accupril
Actonel
Adderal XR
Altace
More...

Related News Articles
 border=
Extra Pounds During and Between Pregnancies Can Pose Problems
Dealing Cervical Cancer a Knockout Blow
Health Tip: Talking to a Person With Alzheimer's Disease
Talk Therapy Proves Effective for Terminal Cancer Patients
More...

THURSDAY, April 26 (HealthDay News) -- Despite earlier hopes, regular use of low-dose aspirin does not protect older, healthy women against cognitive decline, a major new study concludes.

The findings may lay to rest the notion that aspirin can prevent age-related shortfalls in memory and thinking.

Text Continues Below



"I certainly don't think that people should look at taking low-dose aspirin as a preventive measure for cognitive decline," said study author Jae Hee Kang, an instructor of medicine at Brigham and Women's Hospital in Boston. "I think that's pretty clear, especially among those women who are healthy."

Another expert agreed.

"It doesn't slam [the door] shut, but it does kind of close it out," said Dr. Gary Kennedy, director of geriatric psychiatry at Montefiore Medical Center in New York City. "They had a large enough sample that, even for a short period of observation, they should have seen the effect." He was not involved in the study, which was published online Thursday in the British Medical Journal.

Previous evidence had suggested that aspirin and other anti-inflammatory drugs might help protect aging brains from dementia. Larger randomized trials, such as this one, however, had been inconclusive.

Low-dose aspirin does have significant cardiovascular benefits. New expert guidelines recommend that women aged 65 and over consider taking low-dose aspirin on a routine basis, regardless of their cardiovascular risk, to help prevent both heart attacks and stroke. Women under 65 should not be taking aspirin routinely.

But this study focused on brain health. Kang and her colleagues looked at almost 6,400 women, aged 65 or over, who were all participating in the Women's Health Study between 1998 and 2004.

Participants were assessed cognitively every two years by phone. These tests tracked general cognition, verbal memory and category fluency (arranging things quickly by kind).

Page:  1 | 2 | Next >>

Copyright © 2007 ScoutNews, LLC. All rights reserved.
Last updated 4/26/2007

Related Links
 border=
From Healthscout's partner site on alzheimer's disease, OurAlzheimers.com
I need to know about Alzheimer's symptoms.
What are the stages of Alzheimer's Disease?
Learn about Alzheimer's medications.





New Features

New ADHD Site!

SOURCES: Jae Hee Kang, D.Sc., instructor of medicine, Brigham and Women's Hospital, Boston; Gary J. Kennedy, M.D., director, geriatric psychiatry, Montefiore Medical Center, New York City; Sam Gandy, M.D., chairman, Medical and Scientific Advisory Council for the Alzheimer's Association, and director, Farber Institute for Neurosciences, Thomas Jefferson University, Philadelphia; April 26, 2007, online edition, British Medical Journal


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service   Site Map